Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial
2025 · British Journal of Cancer · 7 citations
https://doi.org/10.1038/s41416-025-03097-z
S
Shigeto Maeda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
104
Papers
1.9K
Citations
20
h-index
33
i10-index
Shigeto Maeda is an academic researcher from Nagasaki Municipal Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & Thyroid Cancer Diagnosis and Treatment. The author has an h-index of 20, co-authored 89 publications.
Papers by this author
worksNondegenerated cystic neuroendocrine tumor of the pancreas: a case report
2020 · Surgical Case Reports · 5 citations
https://doi.org/10.1186/s40792-020-00918-6
Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
2021 · International Journal of Clinical Oncology · 3 citations
https://doi.org/10.1007/s10147-021-01920-0
Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study
2021 · Contemporary Clinical Trials Communications · 2 citations
https://doi.org/10.1016/j.conctc.2021.100739
Prognosis of asymptomatic versus symptomatic metastatic breast cancer: a multicenter retrospective study
2022 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-022-18069-z
Cricopharyngeal myotomy for cricopharyngeus muscle dysfunction after esophagectomy
2020 · Surgical Case Reports · 1 citations
https://doi.org/10.1186/s40792-020-00961-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat